Comment on "Second-generation tyrosine kinase inhibitors improve the survival of patients with chronic myeloid leukemia in whom imatinib therapy has failed" Haematologica 2011;96(12):1779-82期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Comment on "Second-generation tyrosine kinase inhibitors improve the survival of patients with chronic myeloid leukemia in whom imatinib therapy has failed" Haematologica 2011;96(12):1779-82

Authors:	Lauseker Michael Pfirrmann Markus Hoffmann Verena S Hasford Joerg

Affiliation:	Institut für medizinische Informationsverarbeitung, Biometrie und Epidemiologie, Ludwig-Maximilians-Universität, München, Germany

Abstract:

Keywords:	imatinib failure chronic myeloid leukemia second-generation tyrosine kinase inhibitors overall survival
本文献已被 PubMed 等数据库收录！